India's GlaxoSmithKline Pharma surges on higher quarterly profit

GlaxoSmithKline Pharmaceuticals

17/02/2025 04:03

** Shares of GlaxoSmithKline Pharmaceuticals  GLAX.NS  jump
12.4% to 2,266 rupees 
    ** Drugmaker reports 35% Y/Y jump in third-quarter adjusted
profit, rev up 18% Y/Y
    ** GLAX's profit growth driven by strong demand for its
respiratory drugs and antibiotic Augmentin, while demand for its
vaccines also boosted earnings
    ** Analysts' avg rating on GLAX at "buy"; median PT is
2,675.50 rupees - data compiled by LSEG 
    ** Stock gained 19% in 2024


 (Reporting by Kashish Tandon in Bengaluru)
 ((Kashish.tandon@thomsonreuters.com))